3,262,471 Shares of Common Stock and Pre-Funded Warrants to Purchase 1,737,529 Shares of Common Stock Neoleukin Therapeutics, Inc. UNDERWRITING AGREEMENT July 1, 2020Underwriting Agreement • July 2nd, 2020 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 2nd, 2020 Company Industry Jurisdiction